Altered glucocorticoid receptor expression and function during mouse skin carcinogenesis

Molecular Carcinogenesis

Volumn 18, Issue 3, 1997, Pages 177-185

  Budunova, Irina V ^a   Carbajal, Steve ^a   Kang, Ho Il ^a   Viaje, Aurora ^a   Slaga, Thomas J ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

Glucocorticoid receptor; Proliferation; Skin tumors

Indexed keywords

7,12 DIMETHYLBENZ[A]ANTHRACENE; FLUOCINOLONE ACETONIDE; GAP JUNCTION PROTEIN; GLUCOCORTICOID RECEPTOR; MESSENGER RNA; METALLOTHIONEIN; PHORBOL 13 ACETATE 12 MYRISTATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; KERATINOCYTE; MOUSE; NONHUMAN; PAPILLOMA; PRIORITY JOURNAL; SKIN CARCINOGENESIS; SQUAMOUS CELL CARCINOMA; TOPICAL DRUG ADMINISTRATION;

9,10-DIMETHYL-1,2-BENZANTHRACENE; ANIMALS; CARCINOGENS; FEMALE; FLUOCINOLONE ACETONIDE; HYPERPLASIA; KERATINOCYTES; MICE; MICE, INBRED STRAINS; PAPILLOMA; RECEPTORS, GLUCOCORTICOID; SKIN; SKIN NEOPLASMS; TETRADECANOYLPHORBOL ACETATE; TRANSCRIPTION FACTORS;

ANIMALIA;

EID: 0030935823     PISSN: 08991987     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2744(199703)18:3<177::AID-MC7>3.0.CO;2-C     Document Type: Article

References (40)

1. Schwartz JA, Viaje A, Slaga TJ, Yuspa SH, Hennings H, Lihta U. Fluocinolone acetonide: A potent inhibitor of mouse skin tumor promotion and epidermal DNA synthesis. Chem Biol Interact 17:331-347, 1977.
2. Slaga TJ. Can tumor promotion be effectively inhibited? IARC Sci Pub 56:497-509, 1984.
3. DiGiovanni J, Kruszewski FH, Chenicek KJ. Modulation of chrysarobin skin tumor promotion. Carcinogenesis 9:1445-1450, 1988.
4. Verma AK, Garcia CT, Ashendel CL, Boutwell RK. Inhibition of 7-brommethyl-benzanthracene-promoted mouse skin tumor formation by retinoic acid and dexamethasone. Cancer Res 43:3045-3049, 1983.
5. Hennings H. Tumor promotion and progression in mouse skin, In: Barrett JC (ed), Multistep Models of Carcinogenesis, CRC Press, Boca Raton, FL, 1987, pp. 59-71.
6. Strowhecker JM, Pelling JC. Inhibition of mouse skin tumorigenesis by dexamethasone occurs through an Ha-ras-independent mechanism. Carcinogenesis 13:2075-2080, 1992.
7. Beato M, Herrlich P, Schultz G. Steroid hormone receptors: Many actors in search of a plot. Cell 83:851-857, 1995.
8. Hollenberg SM, Weinberger C, Ong ES, et al. Primary structure and expression of functional human glucocorticoid receptor cDNA. Nature 318:635-641, 1985.
9. Diamond MI, Miner JN, Yoshinaga SK, Yamamoto KR. Transcriptional factor interactions: Steroids of positive and negative regulation from a single DNA element. Science 249:1266-1272, 1990.
10. Schüle R, Rangarajan P, Kliewer S. Functional antagonism between oncoprotein c-jun and the glucocorticoid receptor. Cell 62:1217-1226, 1990.
11. Ray DW, Littlewood AC, Clark AJ, Davis JRE. Human small cell lung carcinoma cell lines expressing the proopiomelanocortin gene have aberrant glucocorticoid function. J Clin Invest 93:1625-1630, 1994.
12. Oakley RH, Cidlowski JA. Homologous down-regulation of the glucocorticoid receptor: the molecular machinery. Crit Rev Eukariot Gene Expr 32:63-88, 1993.
13. Okret S, Dong Y, Tanaka H, Cairns B, Gustafsson JA. The mechanism of glucocorticoid-resistance in a rat hepatoma variant that contains functional glucocorticoid receptor. J Steroid Biochem Mol Biol 40:353-361, 1991.
14. Langeveld CH, van Waas MP, Stoof JC, et al. Implication of glucocorticoid receptors in the stimulation of human glioma cell proliferation by dexamethasone. J Neurosci Res 31:524-531, 1996.
15. Moali PA, Rosen ST. Glucocorticoid receptors and resistance to glucocorticoids in hematological malignancies. Leuk Lymphoma 15:363-374, 1994.
16. Droms KA, Hanson LA, Malkinson AM, Beer DG. Altered dexamethasone responsiveness and loss of growth control in tumorigenic mouse lung cell lines. Int J Cancer 53:1017-1022, 1993.
17. Krett NL, Pillay S, Moali PA, Griepp PR, Rosen ST. A variant glucocorticoid receptor messenger RNA is expressed in multiple myeloma patients. Cancer Res 55:2727-2729, 1995.
18. Ray DW, Davis JRE, White A, Clark AJL. Glucocorticoid receptor structure and function in glucocorticoid-resistant small cell lung carcinoma cells. Cancer Res 56:3276-3280, 1996.
19. Davidson KA, Slaga TJ. Glucocorticoid receptor levels in mouse skin after repetitive applications of 12-O-tetradecanoylphorbol-13-acetate and mezerein. Cancer Res 43:3847-3851, 1983.
20. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinum thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156-159, 1987.
21. Balmain A, Krumlauf R, Vas JK, Birnie GD. Cloning and characteristic of the abundant cytoplasmic 75 RNA from mouse cells. Nucleic Acids Res 10:4259-4277, 1982.
22. Bradford M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248-254, 1976.
23. Oakley RH, Sar M, Cidlowski JA. The human glucocorticoid receptor β isoform. J Biol Chem 271:9550-9559, 1996.
24. Scatchard G. The attraction of proteins for small molecules. Ann NY Acad Sci 51:660-672, 1949.
25. Yu CW, Lin LY. Cloning and characterization of the 5′-flanking region of metallothionein-I gene from Chinese hamster ovary cells. Biochim Biophys Acta 1262:150-154, 1995.
26. Budunova IV, Carbajal S, Slaga TJ. The expression of gap junctional proteins during different stages of mouse skin carcinogenesis. Carcinogenesis 16:786-795, 1995.
27. Budunova IV, Carbajal S, Slaga TJ. Effect of tumor promoters on connexin expression in SENCAR mouse epidermis. Int J Oncol 7S:998, 1995.
28. Budunova IV, Kang H, Carbajal S, Slaga TJ. Alteration of glucocorticoid receptor expression and function during the tumor promotion stage of mouse skin carcinogenesis. Abstract. Proceedings of the American Association for Cancer Research 37:161, 1996.
29. Chen L, Weiss FR, Chaichik S, Keydar I. Steroid receptors in human renal carcinoma. Isr J Med Sci 16:756-760, 1980.
30. Beattie CW, Hansen NW, Thomas PA. Steroid receptors in human lung cancer. Cancer Res 45:4206-4214, 1985.
31. Lui WY, P'eng FK, Chang YF, Chang TJ, Tsai TF, Hsu ML. Analysis of glucocorticoid receptors in human hepatocellular carcinoma and HepG2 cells. Hepatology 18:1167-1174, 1993.
32. Ray A, Prefontaine KE. Physical association and functional antagonism between the p65 subunit of transcription factor NFkB and the glucocorticoid receptor. Proc Natl Acad Sci USA 91:752-756, 1994.
33. Hashiba H, Hosoi J, Karasawa M, Yamada S, Nose K, Kuroki T. Induction of metallothionein mRNA by tumor promoters in mouse skin and its constitutive expression in papillomas. Mol Carcinog 2:95-100, 1989.
34. Karin M, Andersen RD, Slater E, Smith K, Herschman HR. Metallothionein mRNA induction in HeLa cells in response to zinc or dexamethasone is a primary induction response. Nature 286:295-297, 1980.
35. Hager LJ, Palmiter RD. Transcriptional regulation of mouse liver metallothionein-I gene by glucocorticoids. Nature 291:340-342, 1981.
36. Plisov S, Merkulova TI, Shkapenko AL. Detection of a short segment of DNA responsible for glucocorticoid regulation in the 5′-flanking region on the murine metallothionein-1 gene. Mol Biol (Mosk) 28:407-412, 1994.
37. Hennemann H, Kozjek G, Dahl E, Nicholson BJ, Willecke K. Molecular cloning of mouse connexins 26 and -32: similar genomic organization but distinct promoter sequences of two gap junction genes. Eur J Cell Biol 58:81-89, 1992.
38. Budunova IV, Carbajal S, Slaga TJ. Effect of diverse tumor promoters on the expression of gap-junctional proteins connexin (C×) 26, C×31.1, and C×43 in SENCAR mouse epidermis. Mol Carcinog 15:202-214, 1996.
39. Schreck R, Albermann K, Baeuerle PA. Nuclear factor kB: An oxidative stress-responsive transcription factor of eucariotic cells. Free Radic Res C 17:221-237, 1992
40. Zong J, Ashraf J, Thompson EB. The promoter and first untranslated exon of the human glucocorticoid receptor gene are GC rich but lack consensus glucocorticoid receptor elements sites. Mol Cell Biol 10:5580-5589, 1990.